In conclusion, our findings offer a convenient and non-invasive for early diagnosis and prediction of outcomes for patients with CRC, as the blood-based IGFBP-1 are easy to obtain from routine admission laboratory tests. This evidence concerns the gene IGFBP1 and colorectal carcinoma.